- Home
- PTGX vs SGHC Comparison
PTGX vs SGHC Comparison
Compare PTGX & SGHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTGX
- SGHC
- Stock Information
- Founded
- PTGX 2006
- SGHC 2020
- Country
- PTGX United States
- SGHC Guernsey
- Employees
- PTGX N/A
- SGHC N/A
- Industry
- PTGX Biotechnology: Pharmaceutical Preparations
- SGHC Services-Misc. Amusement & Recreation
- Sector
- PTGX Health Care
- SGHC Consumer Discretionary
- Exchange
- PTGX Nasdaq
- SGHC Nasdaq
- Market Cap
- PTGX 2.8B
- SGHC 1.8B
- IPO Year
- PTGX 2016
- SGHC N/A
- Fundamental
- Price
- PTGX $47.91
- SGHC $4.17
- Analyst Decision
- PTGX Strong Buy
- SGHC Strong Buy
- Analyst Count
- PTGX 7
- SGHC 2
- Target Price
- PTGX $52.83
- SGHC $5.50
- AVG Volume (30 Days)
- PTGX 450.1K
- SGHC 325.4K
- Earning Date
- PTGX 11-08-2024
- SGHC 11-06-2024
- Dividend Yield
- PTGX N/A
- SGHC N/A
- EPS Growth
- PTGX N/A
- SGHC N/A
- EPS
- PTGX 2.75
- SGHC 0.01
- Revenue
- PTGX $319,120,000.00
- SGHC $1,618,776,385.00
- Revenue This Year
- PTGX $400.33
- SGHC $11.34
- Revenue Next Year
- PTGX N/A
- SGHC $8.57
- P/E Ratio
- PTGX $17.54
- SGHC $351.26
- Revenue Growth
- PTGX 125.73
- SGHC 11.40
- 52 Week Low
- PTGX $13.76
- SGHC $2.63
- 52 Week High
- PTGX $48.89
- SGHC $4.25
- Technical
- Relative Strength Index (RSI)
- PTGX 60.40
- SGHC 72.35
- Support Level
- PTGX $45.33
- SGHC $4.10
- Resistance Level
- PTGX $48.89
- SGHC $4.25
- Average True Range (ATR)
- PTGX 1.28
- SGHC 0.10
- MACD
- PTGX 0.11
- SGHC -0.01
- Stochastic Oscillator
- PTGX 77.11
- SGHC 82.76
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
About SGHC Super Group (SGHC) Limited
Super Group (SGHC) Ltd is a holding company that operates global online sports betting and gaming businesses. The company has two reportable segments, namely Betway and Spin. The majority of the company's revenue comes from the Betway segment, which is a single-brand online sportsbook business with a global reach. Betway has formed strategic partnerships with teams and leagues across the world and recovers sponsorship marketing spend through brand license agreements. The Betway segment generates the majority of the company's revenue.